Angiodynamics, Inc. (($ANGO)) announced an update on their ongoing clinical study. Angiodynamics, Inc. has announced a new clinical study titled ...

After a progression-free survival win last year raised hopes for the combo's potential in hepatocellular carcinoma, an overall survival miss brings the study to a close.

Advances in systemic and local therapies are helping more live longer with liver cancer and move forward after treatment as ...

Merck and Japan's Eisai said on Wednesday they will shut down a late-stage study testing an experimental combination therapy ...

During Liver Cancer Awareness Month, Dr. Anjana Pillai says more treatment options, growing trials and ongoing research offer ...

A number of studies have shown potential benefits to aspirin for the prevention of colon cancer and other digestive tract cancers. Previous observational studies have suggested that aspirin has a role ...

Chinese researchers have revealed a mechanism that triggers metastasis of hepatocellular carcinoma (HCC)—the most common type ...

Liver cirrhosis is significantly more common in low-income households than in high-income households. This is the result of a ...